About Vaks Pharma Private Limited
Data last updated:
Vaks Pharma Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 24 October 2001 and has been in existence for over 25 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U51397MH2001PTC133776. Its GSTIN is 27AAACM3981F1ZG (Maharashtra). The company holds 2 GST registrations, all of them active.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Arjun Vijaykumar Panikar and Siddharth Vijay Panikar.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at F 21 1st Floor Kohinoor Mall Kirol Road Kurla West, Mumbai, Maharashtra, India – 400070.
As per the financials filed for FY 2024, the company reported a revenue of ₹19.45 Cr, a growth of 28% compared to the previous year. For the same year it recorded a net profit of ₹58.6 Lakh (net margin 3%) and EBITDA of ₹86.43 Lakh (EBITDA margin 4.4%). Revenue has grown at a compounded annual rate (CAGR) of 44% over three years and 4% over five years.
The company is associated with 1 brand: VAKS Pharma. As per MCA filings, the company has open charges of ₹38 Lakh on record.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website vakspharma.com.
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Registered AddressF 21 1st Floor Kohinoor Mall Kirol Road Kurla West, Mumbai, Maharashtra, India – 400070
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Vaks Pharma Private Limited
The main business activity of Vaks Pharma is trade. In detail, this covers wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Vaks Pharma Private Limited FY 2025 filings available
Vaks Pharma Private Limited reported revenue of ₹19.45 Cr (up 28% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR) of Vaks Pharma Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 4% over five years, including 28% growth in the latest year. EBITDA rose 23% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Vaks Pharma Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹86.43 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹58.6 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Vaks Pharma Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 4.4% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 3% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Vaks Pharma are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Vaks Pharma Private Limited
Vaks Pharma Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Formulations). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Estrellas Life Sciences Private Limited | ₹19.63 Cr (FY 2025) | •••• | •••• | 8.0% | •••• | Ahmedabad, Gujarat, India |
| Equatorial Private Limited | ₹19.61 Cr (FY 2018) | •••• | •••• | 22832.0% | •••• | Ahmedabad, Gujarat, India |
| Emmar Chem Industries Pvt Ltd | ₹19.6 Cr (FY 2024) | •••• | •••• | 29.0% | •••• | Boisar, Maharashtra, India |
| Trugen Pharmaceuticals Private Limited | ₹19.49 Cr (FY 2025) | •••• | •••• | -11.0% | •••• | Roorkee, Uttarakhand, India |
| Anamay Biotech Private Limited | ₹19.48 Cr (FY 2025) | •••• | •••• | 14.0% | •••• | Hyderabad, Telangana, India |
| Vaks Pharma Private Limited this company | ₹19.45 Cr (FY 2024) | •••• | •••• | 28.0% | •••• | Mumbai, Maharashtra, India |
| Aurz Pharmaceutical Private Limited | ₹19.44 Cr (FY 2025) | •••• | •••• | 10.0% | •••• | Bangalore, Karnataka, India |
| Veco Labs Private Limited | ₹19.44 Cr (FY 2024) | •••• | •••• | 13.0% | •••• | Hyderabad, Telangana, India |
| G Nine Bioceuticals Private Limited | ₹19.42 Cr (FY 2025) | •••• | •••• | 5.0% | •••• | Karnal, Haryana, India |
| Avlaan Pharmaceutical Private Limited | ₹19.36 Cr (FY 2024) | •••• | •••• | 28.0% | •••• | Chennai, Tamil Nadu, India |
| Medic Biologicals and Pharmaceuticals Private Limited | ₹19.33 Cr (FY 2025) | •••• | •••• | 26.0% | •••• | Thiruvananthapuram, Kerala, India |
Peers are the five companies nearest above and the five nearest below Vaks Pharma by revenue in the Pharma industry (Formulations), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Vaks Pharma Private Limited
Vaks Pharma Private Limited is audited by Nadkarni Date & Associates LLP for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| Nadkarni Date & Associates LLP | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Vaks Pharma Private Limited
Vaks Pharma has 2 current directors and 5 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Arjun Vijaykumar Panikar Also directs: Mitoch Pharma Private Limited, Mccoy Pharma Private Limited | Director | 21 Aug 2018 | 8 Years 1 Months | Current |
| Siddharth Vijay Panikar Also directs: Mitoch Pharma Private Limited, Mccoy Pharma Private Limited, P. N. Packaging Private Limited and 1 more | Director | 20 Jul 2007 | 19 Years 2 Months | Current |
Ownership and Shareholding of Vaks Pharma Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Vaks Pharma Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 05 Apr 2024 | Others | ₹38 Lakh | Open |
Total charge records: 1 View all charges
MSME Payment Delays by Vaks Pharma Private Limited
Vaks Pharma Private Limited has 1 MSME Form 1 return on record for the period ending Mar 2021, listing 1 overdue payment to 1 micro and small supplier. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (1 of 1)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| an individual supplier | •••• | •••• | •••• |
Full MSME payment history
Every supplier, amount and due date from all 1 MSME Form 1 returns is in the company report.
- Every reported supplier due
- Amounts and due dates
- Reasons given in each return
- Period-by-period history
Verified entity values are shown only after access is granted.
Individuals and sole proprietors among the suppliers are not named. Amounts, due dates and filing dates are in the company report.
Associated Brands with Vaks Pharma Private Limited
Vaks Pharma operates one associated brand: VAKS Pharma. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Manufacturing and exporting of pharmaceutical formulations and generics in India. | vakspharma.com |
Employees and EPFO Compliance at Vaks Pharma Private Limited
Employment history and EPFO contributions of people linked to Vaks Pharma.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Vaks Pharma Private Limited
Vaks Pharma Private Limited has 7 board changes on record since 2007: 2 appointments and 5 cessations. The latest: Arjun Vijaykumar Panikar ceased to be Additional Director on 29 Sep 2018.
Credit Ratings, Litigation & Regulatory Alerts for Vaks Pharma Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Vaks Pharma Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Vaks Pharma Private Limited
Vaks Pharma has 2 GST registrations: 2 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAACM3981F1ZG | Maharashtra | Active | 01 Jul 2017 |
| 27AACCV3502F1ZO | Maharashtra | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Vaks Pharma Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Vaks Pharma Private Limited
Vaks Pharma is an active private limited company based in Mumbai, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 24 October 2001 (25+ years old) and is registered under CIN U51397MH2001PTC133776.
Vaks Pharma reported revenue of ₹19.45 Cr for FY 2024 (up 28% YoY).
Vaks Pharma has 2 current directors:
- Arjun Vijaykumar Panikar - Director
- Siddharth Vijay Panikar - Director
Vaks Pharma reported a net profit of ₹58.6 Lakh (net margin 3%) and EBITDA of ₹86.43 Lakh (EBITDA margin 4.4%) for FY 2024, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Vaks Pharma is 44% over three years and 4% over five years. In the latest year (FY 2024) revenue rose 28%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Vaks Pharma is 27AAACM3981F1ZG, registered in Maharashtra. The company has 2 GST registrations in all, of which 2 are active. Other active GSTINs include 27AACCV3502F1ZO (Maharashtra).
The CIN (Corporate Identification Number) of Vaks Pharma is U51397MH2001PTC133776. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Vaks Pharma was incorporated on 24 October 2001, making it 25+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Vaks Pharma by revenue are Estrellas Life Sciences Private Limited, Equatorial Private Limited, Emmar Chem Industries Pvt Ltd, Trugen Pharmaceuticals Private Limited, Anamay Biotech Private Limited and 5 more, all in the Pharma industry (Formulations).
Arjun Vijaykumar Panikar ceased to be Additional Director on 29 Sep 2018. Prasanna Kumar Panikkar ceased to be Director on 29 Aug 2018. Arjun Vijaykumar Panikar was appointed as Director on 21 Aug 2018. Vaks Pharma has 7 board changes on record in total.
Vaks Pharma has 1 MSME Form 1 return on record for the period ending Mar 2021, listing 1 overdue payment to 1 micro and small supplier. The latest return was filed on 30 Aug 2021.
Vaks Pharma can be reached through the website vakspharma.com. Its registered office is in Mumbai, Maharashtra, India.